APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncolytic Virus

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Selected research

Market Analysis & Forecast

Global Oncolytic Virus Market Analysis and Forecast 2026-2032

30 December 2025190 pages

Choose your research edition.

Industry ResearchOncolytic Virus Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncolytic Virus Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Oncolytic Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncolytic Virus Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncolytic Virus Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

This report presents an overview of global market for Oncolytic Virus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Oncolytic Virus, also provides the sales of main regions and countries. Of the upcoming market potential for Oncolytic Virus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncolytic Virus sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oncolytic Virus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oncolytic Virus sales, projected growth trends, production technology, application and end-user industry.

Oncolytic Virus Segment by Company

Amgen

Shanghai Sunway Biotech

Oncolytic Virus Segment by Type

Imlygic

Oncorine

Others

Oncolytic Virus Segment by Application

Melanoma

Other Cancers

Oncolytic Virus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oncolytic Virus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Imlygic Major Manufacturers Table 3. Oncorine Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Oncolytic Virus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Melanoma Major Manufacturers Table 7. Other Cancers Major Manufacturers Table 8. Oncolytic Virus Industry Trends Table 9. Oncolytic Virus Industry Drivers Table 10. Oncolytic Virus Industry Opportunities and Challenges Table 11. Oncolytic Virus Industry Restraints Table 12. Global Oncolytic Virus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Oncolytic Virus Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Oncolytic Virus Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Oncolytic Virus Revenue Market Share by Region (2021-2026) Table 16. Global Oncolytic Virus Revenue Market Share by Region (2027-2032) Table 17. Global Oncolytic Virus Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Oncolytic Virus Sales by Region (2021-2026) & (K Units) Table 19. Global Oncolytic Virus Sales by Region (2027-2032) & (K Units) Table 20. Global Oncolytic Virus Sales Market Share by Region (2021-2026) Table 21. Global Oncolytic Virus Sales Market Share by Region (2027-2032) Table 22. Global Oncolytic Virus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Oncolytic Virus Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Oncolytic Virus Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Oncolytic Virus Sales Market Share by Manufacturers (2021-2026) Table 26. Global Oncolytic Virus Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Oncolytic Virus Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Oncolytic Virus Manufacturers, Product Type & Application Table 30. Global Oncolytic Virus Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Oncolytic Virus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Oncolytic Virus Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Oncolytic Virus Revenue Market Share by Type (2021-2026) Table 37. Global Oncolytic Virus Revenue Market Share by Type (2027-2032) Table 38. Global Oncolytic Virus Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 40. Global Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 41. Global Oncolytic Virus Sales Market Share by Type (2021-2026) Table 42. Global Oncolytic Virus Sales Market Share by Type (2027-2032) Table 43. Global Oncolytic Virus Price by Type (2021-2026) & (US$/Unit) Table 44. Global Oncolytic Virus Price by Type (2027-2032) & (US$/Unit) Table 45. Global Oncolytic Virus Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Oncolytic Virus Revenue Market Share by Application (2021-2026) Table 49. Global Oncolytic Virus Revenue Market Share by Application (2027-2032) Table 50. Global Oncolytic Virus Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 52. Global Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 53. Global Oncolytic Virus Sales Market Share by Application (2021-2026) Table 54. Global Oncolytic Virus Sales Market Share by Application (2027-2032) Table 55. Global Oncolytic Virus Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oncolytic Virus Price by Application (2027-2032) & (US$/Unit) Table 57. Amgen Company Information Table 58. Amgen Business Overview Table 59. Amgen Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Amgen Oncolytic Virus Product Portfolio Table 61. Amgen Recent Development Table 62. Shanghai Sunway Biotech Company Information Table 63. Shanghai Sunway Biotech Business Overview Table 64. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shanghai Sunway Biotech Oncolytic Virus Product Portfolio Table 66. Shanghai Sunway Biotech Recent Development Table 67. North America Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 70. North America Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 71. North America Oncolytic Virus Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Oncolytic Virus Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 76. North America Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 77. North America Oncolytic Virus Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Oncolytic Virus Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Oncolytic Virus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Oncolytic Virus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 84. North America Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 85. North America Oncolytic Virus Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Oncolytic Virus Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 88. Canada Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 89. Mexico Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 90. Europe Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 93. Europe Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 94. Europe Oncolytic Virus Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Oncolytic Virus Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 99. Europe Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 100. Europe Oncolytic Virus Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Oncolytic Virus Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Oncolytic Virus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Oncolytic Virus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 107. Europe Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 108. Europe Oncolytic Virus Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Oncolytic Virus Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 111. France Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 112. U.K. Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 113. Italy Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 114. Russia Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 115. Spain Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 118. Sweden Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 119. Poland Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 120. China Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 121. China Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 122. China Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 123. China Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 124. China Oncolytic Virus Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Oncolytic Virus Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 127. China Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 128. China Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 129. China Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 130. China Oncolytic Virus Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Oncolytic Virus Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 135. Asia Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 136. Asia Oncolytic Virus Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Oncolytic Virus Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 141. Asia Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 142. Asia Oncolytic Virus Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Oncolytic Virus Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Oncolytic Virus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Oncolytic Virus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 149. Asia Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 150. Asia Oncolytic Virus Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Oncolytic Virus Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 153. South Korea Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 154. India Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 155. Australia Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Oncolytic Virus Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Oncolytic Virus Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Oncolytic Virus Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Oncolytic Virus Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Oncolytic Virus Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Oncolytic Virus Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Oncolytic Virus Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Oncolytic Virus Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Oncolytic Virus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Oncolytic Virus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Oncolytic Virus Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Oncolytic Virus Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 179. Argentina Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 180. Chile Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 181. Colombia Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 182. Peru Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 184. Israel Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 185. UAE Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 186. Turkey Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 187. Iran Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 188. Egypt Oncolytic Virus Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Oncolytic Virus Distributors List Table 192. Oncolytic Virus Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Oncolytic Virus Image Figure 2. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncolytic Virus Market Size Share 2021 VS 2025 VS 2032 Figure 4. Imlygic Image Figure 5. Oncorine Image Figure 6. Others Image Figure 7. Global Oncolytic Virus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Oncolytic Virus Market Size Share 2021 VS 2025 VS 2032 Figure 9. Melanoma Image Figure 10. Other Cancers Image Figure 11. Global Oncolytic Virus Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oncolytic Virus Revenue (2021-2032) & (US$ Million) Figure 13. Global Oncolytic Virus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Oncolytic Virus Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Oncolytic Virus Revenue Market Share by Region (2021-2032) Figure 16. Global Oncolytic Virus Sales (2021-2032) & (K Units) Figure 17. Global Oncolytic Virus Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Oncolytic Virus Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Oncolytic Virus Sales YoY (2021-2032) & (K Units) Figure 20. Europe Oncolytic Virus Sales YoY (2021-2032) & (K Units) Figure 21. China Oncolytic Virus Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Oncolytic Virus Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Oncolytic Virus Sales YoY (2021-2032) & (K Units) Figure 24. Global Oncolytic Virus Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Oncolytic Virus Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Oncolytic Virus Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Oncolytic Virus Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Oncolytic Virus Revenue Market Share by Type (2021-2032) Figure 30. Global Oncolytic Virus Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Oncolytic Virus Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Oncolytic Virus Sales Market Share by Type (2021-2032) Figure 33. Global Oncolytic Virus Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Oncolytic Virus Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Oncolytic Virus Revenue Market Share by Application (2021-2032) Figure 36. Global Oncolytic Virus Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Oncolytic Virus Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Oncolytic Virus Sales Market Share by Application (2021-2032) Figure 39. North America Oncolytic Virus Revenue Share by Type (2021-2032) Figure 40. North America Oncolytic Virus Sales Share by Type (2021-2032) Figure 41. North America Oncolytic Virus Revenue Share by Application (2021-2032) Figure 42. North America Oncolytic Virus Sales Share by Application (2021-2032) Figure 43. North America Oncolytic Virus Revenue Share by Country (2021-2032) Figure 44. North America Oncolytic Virus Sales Share by Country (2021-2032) Figure 45. Europe Oncolytic Virus Revenue Share by Type (2021-2032) Figure 46. Europe Oncolytic Virus Sales Share by Type (2021-2032) Figure 47. Europe Oncolytic Virus Revenue Share by Application (2021-2032) Figure 48. Europe Oncolytic Virus Sales Share by Application (2021-2032) Figure 49. Europe Oncolytic Virus Revenue Share by Country (2021-2032) Figure 50. Europe Oncolytic Virus Sales Share by Country (2021-2032) Figure 51. China Oncolytic Virus Revenue Share by Type (2021-2032) Figure 52. China Oncolytic Virus Sales Share by Type (2021-2032) Figure 53. China Oncolytic Virus Revenue Share by Application (2021-2032) Figure 54. China Oncolytic Virus Sales Share by Application (2021-2032) Figure 55. Asia Oncolytic Virus Revenue Share by Type (2021-2032) Figure 56. Asia Oncolytic Virus Sales Share by Type (2021-2032) Figure 57. Asia Oncolytic Virus Revenue Share by Application (2021-2032) Figure 58. Asia Oncolytic Virus Sales Share by Application (2021-2032) Figure 59. Asia Oncolytic Virus Revenue Share by Country (2021-2032) Figure 60. Asia Oncolytic Virus Sales Share by Country (2021-2032) Figure 61. SAMEA Oncolytic Virus Revenue Share by Type (2021-2032) Figure 62. SAMEA Oncolytic Virus Sales Share by Type (2021-2032) Figure 63. SAMEA Oncolytic Virus Revenue Share by Application (2021-2032) Figure 64. SAMEA Oncolytic Virus Sales Share by Application (2021-2032) Figure 65. SAMEA Oncolytic Virus Revenue Share by Country (2021-2032) Figure 66. SAMEA Oncolytic Virus Sales Share by Country (2021-2032) Figure 67. Oncolytic Virus Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Oncolytic Virus Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Imlygic
  • Oncorine
  • Others
Applications
  • Melanoma
  • Other Cancers
Companies covered
  • Amgen
  • Shanghai Sunway Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oncolytic Virus Market by Type
  3. 1.2.1 Global Oncolytic Virus Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Imlygic
  5. 1.2.3 Oncorine
  6. 1.2.4 Others
  7. 1.3 Oncolytic Virus Market by Application
  8. 1.3.1 Global Oncolytic Virus Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Melanoma
  10. 1.3.3 Other Cancers
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Oncolytic Virus Market Dynamics
  1. 2.1 Oncolytic Virus Industry Trends
  2. 2.2 Oncolytic Virus Industry Drivers
  3. 2.3 Oncolytic Virus Industry Opportunities and Challenges
  4. 2.4 Oncolytic Virus Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oncolytic Virus Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oncolytic Virus Revenue by Region
  3. 3.2.1 Global Oncolytic Virus Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oncolytic Virus Revenue by Region (2021-2026)
  5. 3.2.3 Global Oncolytic Virus Revenue by Region (2027-2032)
  6. 3.2.4 Global Oncolytic Virus Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oncolytic Virus Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oncolytic Virus Sales by Region
  9. 3.4.1 Global Oncolytic Virus Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oncolytic Virus Sales by Region (2021-2026)
  11. 3.4.3 Global Oncolytic Virus Sales by Region (2027-2032)
  12. 3.4.4 Global Oncolytic Virus Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oncolytic Virus Revenue by Manufacturers
  2. 4.1.1 Global Oncolytic Virus Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oncolytic Virus Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oncolytic Virus Sales by Manufacturers
  6. 4.2.1 Global Oncolytic Virus Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oncolytic Virus Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oncolytic Virus Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oncolytic Virus Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oncolytic Virus Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oncolytic Virus Manufacturers, Product Type & Application
  13. 4.7 Global Oncolytic Virus Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oncolytic Virus Market CR5 and HHI
  16. 4.8.2 2025 Oncolytic Virus Tier 1, Tier 2, and Tier 3
5 Oncolytic Virus Market by Type
  1. 5.1 Global Oncolytic Virus Revenue by Type
  2. 5.1.1 Global Oncolytic Virus Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oncolytic Virus Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oncolytic Virus Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oncolytic Virus Sales by Type
  6. 5.2.1 Global Oncolytic Virus Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oncolytic Virus Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oncolytic Virus Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oncolytic Virus Price by Type
6 Oncolytic Virus Market by Application
  1. 6.1 Global Oncolytic Virus Revenue by Application
  2. 6.1.1 Global Oncolytic Virus Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oncolytic Virus Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oncolytic Virus Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oncolytic Virus Sales by Application
  6. 6.2.1 Global Oncolytic Virus Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oncolytic Virus Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oncolytic Virus Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oncolytic Virus Price by Application
7 Company Profiles
  1. 7.1 Amgen
  2. 7.1.1 Amgen Company Information
  3. 7.1.2 Amgen Business Overview
  4. 7.1.3 Amgen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Oncolytic Virus Product Portfolio
  6. 7.1.5 Amgen Recent Developments
  7. 7.2 Shanghai Sunway Biotech
  8. 7.2.1 Shanghai Sunway Biotech Company Information
  9. 7.2.2 Shanghai Sunway Biotech Business Overview
  10. 7.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
  12. 7.2.5 Shanghai Sunway Biotech Recent Developments
8 North America
  1. 8.1 North America Oncolytic Virus Market Size by Type
  2. 8.1.1 North America Oncolytic Virus Revenue by Type (2021-2032)
  3. 8.1.2 North America Oncolytic Virus Sales by Type (2021-2032)
  4. 8.1.3 North America Oncolytic Virus Price by Type (2021-2032)
  5. 8.2 North America Oncolytic Virus Market Size by Application
  6. 8.2.1 North America Oncolytic Virus Revenue by Application (2021-2032)
  7. 8.2.2 North America Oncolytic Virus Sales by Application (2021-2032)
  8. 8.2.3 North America Oncolytic Virus Price by Application (2021-2032)
  9. 8.3 North America Oncolytic Virus Market Size by Country
  10. 8.3.1 North America Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oncolytic Virus Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oncolytic Virus Market Size by Type
  2. 9.1.1 Europe Oncolytic Virus Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oncolytic Virus Sales by Type (2021-2032)
  4. 9.1.3 Europe Oncolytic Virus Price by Type (2021-2032)
  5. 9.2 Europe Oncolytic Virus Market Size by Application
  6. 9.2.1 Europe Oncolytic Virus Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oncolytic Virus Sales by Application (2021-2032)
  8. 9.2.3 Europe Oncolytic Virus Price by Application (2021-2032)
  9. 9.3 Europe Oncolytic Virus Market Size by Country
  10. 9.3.1 Europe Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oncolytic Virus Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oncolytic Virus Market Size by Type
  2. 10.1.1 China Oncolytic Virus Revenue by Type (2021-2032)
  3. 10.1.2 China Oncolytic Virus Sales by Type (2021-2032)
  4. 10.1.3 China Oncolytic Virus Price by Type (2021-2032)
  5. 10.2 China Oncolytic Virus Market Size by Application
  6. 10.2.1 China Oncolytic Virus Revenue by Application (2021-2032)
  7. 10.2.2 China Oncolytic Virus Sales by Application (2021-2032)
  8. 10.2.3 China Oncolytic Virus Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oncolytic Virus Market Size by Type
  2. 11.1.1 Asia Oncolytic Virus Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oncolytic Virus Sales by Type (2021-2032)
  4. 11.1.3 Asia Oncolytic Virus Price by Type (2021-2032)
  5. 11.2 Asia Oncolytic Virus Market Size by Application
  6. 11.2.1 Asia Oncolytic Virus Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oncolytic Virus Sales by Application (2021-2032)
  8. 11.2.3 Asia Oncolytic Virus Price by Application (2021-2032)
  9. 11.3 Asia Oncolytic Virus Market Size by Country
  10. 11.3.1 Asia Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oncolytic Virus Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oncolytic Virus Market Size by Type
  2. 12.1.1 SAMEA Oncolytic Virus Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oncolytic Virus Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oncolytic Virus Price by Type (2021-2032)
  5. 12.2 SAMEA Oncolytic Virus Market Size by Application
  6. 12.2.1 SAMEA Oncolytic Virus Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oncolytic Virus Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oncolytic Virus Price by Application (2021-2032)
  9. 12.3 SAMEA Oncolytic Virus Market Size by Country
  10. 12.3.1 SAMEA Oncolytic Virus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oncolytic Virus Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oncolytic Virus Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oncolytic Virus Value Chain Analysis
  2. 13.1.1 Oncolytic Virus Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oncolytic Virus Production Mode & Process
  6. 13.2 Oncolytic Virus Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oncolytic Virus Distributors
  9. 13.2.3 Oncolytic Virus Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst